Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

24.13
-0.2100-0.86%
Volume:323.37K
Turnover:7.75M
Market Cap:1.12B
PE:-10.64
High:24.35
Open:24.35
Low:23.50
Close:24.34
Loading ...
OverviewCompanyNewsFilings

Pacira Biosciences: Sees Double-Digit Compounded Annual Growth Rate in Product Revenue by 2030

THOMSON REUTERS
·
10 Jan

FDA Clears PCRX's New Iovera Smart Tip for Expanded Use in Pain Relief

Zacks
·
09 Jan

Pacira BioSciences Secures FDA Approval For New iovera SmartTip to Manage Chronic Low Back Pain

Benzinga
·
08 Jan

Pacira Biosciences Gets FDA Clearance for Chronic Low Back Pain Treatment

MT Newswires Live
·
07 Jan

Pacira receives 510k clearance for iovera Smart Tip

TIPRANKS
·
07 Jan

BRIEF-Pacira Biosciences Receives FDA 510K Clearance For New Iovera° Smarttip To Manage Chronic Low Back Pain Via Long-Lasting Medial Branch Nerve Block

Reuters
·
07 Jan

Pacira Biosciences Receives FDA 510K Clearance for New Iovera° Smarttip to Manage Chronic Low Back Pain via Long-Lasting Medial Branch Nerve Block

THOMSON REUTERS
·
07 Jan

RBC Raises Price Target on Pacira Biosciences to $18 From $16, Keeps Sector Perform Rating

MT Newswires Live
·
07 Jan

Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
03 Jan

Here's Why Pacira (PCRX) is a Strong Momentum Stock

Zacks
·
18 Dec 2024

Analyst Rate

Hold
Buy
42.86%
Hold
42.86%
Sell
14.29%

Corporate Actions

Financial Report Announcement
May 08, 2025 Post Market
Financial Report Announcement
Feb 27, 2025 Post Market
Financial Report Announcement
Jan 10, 2025 Pre-Market
Financial Report Announcement
Nov 06, 2024 Post Market
Financial Report Announcement
Jul 30, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-11.10
Current
-793.44
Sector Average
24.53%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-11.10
Maximum
223.31
+1 STD
3,636.15
Minimum
-28,309.06
-1 STD
-5,223.02
Average
-793.44

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.